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The extracisternal approach in vestibular
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A abordagem extracisternal na cirurgia de schwannoma vestibular e preservação do nervo
facial
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ABSTRACT
The classical surgical technique for the resection of vestibular schwannomas (VS) has emphasized the microsurgical anatomy of cranial
nerves. We believe that the focus on preservation of the arachnoid membrane may serve as a safe guide for tumor removal. Method: The
extracisternal approach is described in detail. We reviewed charts from 120 patients treated with this technique between 2006 and 2012.
Surgical results were evaluated based on the extension of resection, tumor relapse, and facial nerve function. Results: Overall gross total
resection was achieved in 81% of the patients. The overall postoperative facial nerve function House-Brackmann grades I-II at one year
was 93%. There was no recurrence in 4.2 years mean follow up. Conclusion: The extracisternal technique differs from other surgical
descriptions on the treatment of VS by not requiring the identification of the facial nerve, as long as we preserve the arachnoid envelope in
the total circumference of the tumor.
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RESUMO
A técnica cirúrgica clássica para ressecção de schwannomas vestibulares enfatiza a anatomia microcirúrgica dos nervos cranianos.
Acreditamos que o foco na preservação da membrana aracnóide pode servir como parâmetro seguro para a remoção do tumor. Método: A
abordagem extracisternal é descrita em detalhe. Analisamos o prontuário de 120 pacientes tratados com esta técnica entre 2006 e 2012.
Os resultados cirúrgicos foram baseados em extensão de ressecção, recorrência tumoral e função do nervo facial. Resultados: Ressecção
total foi obtida em 81% dos pacientes. O resultado global da função do nervo facial (House-Brackmann graus I-II) após um ano da cirurgia
foi de 93%. Não houve recidiva em um seguimento médio de 4,2 anos. Conclusão: A técnica extracisternal difere de outras descrições
cirúrgicas no tratamento de schwannoma vestibular pois não requer a identificação do nervo facial, contanto que o plano de aracnóide
seja preservado em toda circunferência do tumor.
Palavras-chave: membrana aracnóide, nervo facial, cirurgia, schwannoma vestibular, neurinoma do acústico.
Facial nerve injury is a common complication in the treat-
ment of vestibular schwannomas (VS) and its associated
facial muscle palsy has a great impact in patients’ quality
of life1. This is the reason why functional preservation of
the facial nerve is sought when managing VS with either
radiosurgery or microsurgery. Several factors have been cor-
related with worse facial nerve function outcomes, including
older patients, large tumors, and preoperative facial nerve
function2,3,4. Although careful facial nerve dissection is pur-
sued, anatomical preservation of the facial nerve is not syn-
onymous of normal function5,6,7. Intraoperative monitoring
of the facial nerve is the key for optimal facial nerve preser-
vation, even though not all patients’ clinical courses correlate
with their intraoperative electrophysiological result6,8.
The classical descriptions of the surgical technique for
VS removal has constantly emphasized the microsurgical
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anatomy in order to ease the identification of the cranial
nerves and its relationship to the tumor capsule at the cer-
ebellopontine angle (CPA). There are four classical steps in
the surgical removal of acoustic tumors: (1) intracapsular
tumor removal; (2) identification of the facial and cochlear
nerves at the internal auditory canal (IAC); (3) nerve iden-
tification and dissection medially next to the brainstem;
and (4) complete removal of the tumor under direct vision
of those structures.
In the present study, we describe the technical nuances
of the extracisternal approach for removal of VS, discuss
its advantage, and report our results. Based on the relation-
ship of the tumor with the complex arachnoid membranes at
the CPA, we propose a change of the paradigm of the surgery.
Instead of identifying and using the facial nerve as a surgical
anatomical landmark, we perform the dissection inside the
tumor preserving an arachnoid envelope that protects facial
and cochlear nerves during tumor removal. The goal is to
obtain an arachnoid veil at the CPA after the tumor removal,
where the facial nerve is barely seen through it. The lesser
exposure of the facial nerve the better is the functional result.
METHOD
The extracisternal approach was described in detail in a
retrosigmoid craniotomy. We retrospectively reviewed charts
from 120 patients treated for VS with this technique by the
same neurosurgeon (EASV) at private hospitals in Sao Paulo
(Brazil) between 2006 and 2012. Patients with documented
neurofibromatosis type II, preoperative facial nerve palsy
and any previous treatment with microsurgery or radiosur-
gery were excluded from the analysis.
Preoperative evaluation included complete neurological
examination, brain magnetic resonance imaging (MRI) and
audiometry. Tumor size was designated based on the max-
imum extra-meatal diameter. Surgery was indicated in
patients with tumor size greater than 20 mm independently
of age, patients younger than 50 years old with any tumor
size, and in patients with age greater than 50 years old with
increasing tumor size while on the “wait and scan” manage-
ment. The retrosigmoid suboccipital craniotomy was the
preferred approach and routine intraoperative neurophysio-
logic monitoring was performed.
We divided patients in five grades according to the extra-
meatal tumor size (0-10 mm, 11-20 mm, 21-30 mm, 31-40 mm
and .40mm)9. Surgical results were evaluated based on the
extension of resection, tumor relapse, and facial nerve function.
Gross total resection (GTR) was designated when no
tumor was knowingly left behind; near-total resection
(NTR) was applied when a tumor remnant smaller than
5x5x2 mm was intentionally left in situ to lessen neuro-
logical morbidity; and subtotal removal (STR) was used
when anything more was left behind10. The tumor relapse
was evaluated with follow up brain MRI at two months,
one year, two years and five years after the surgery.
Significant regrowth was defined as residual tumor fragment
expansion of at least 5 mm from the postoperative size. Not
all patients had a five years follow up due to the recent pro-
cedures, however all patients have at least one-year follow
up for the evaluation of tumor recurrence and facial nerve
function. Any postoperative complications were noted.
Facial nerve function was analyzed at the immediate and
at one-year postoperative period according to the House-
Brackmann (HB) classification11. HB I-II were defined as
good outcome, HB III as regular outcome and HB IV-V-VI
as poor outcome.
RESULTS
Surgical technique
The principles of the extracisternal dissection are repro-
ducible in any surgical approach for VS (suboccipital
retrosigmoid or translabirynthine). As the retrosigmoid
craniotomy was the most commonly used, it is the chosen
approach for the technique description.
The patient is positioned in supine with rotated shoulders
30 degrees and the head tilted 45 degrees to the contralateral
side. After a classical suboccipital craniotomy limited laterally
by the sigmoid sinus and superiorly by the transverse sinus,
the dura is opened in a laterally convexed “C” shape.
Drainage of cerebrospinal fluid (CSF) from basal cisterns facil-
itates tumor exposure in the CPA and visibility of the posterior
wall of IAC with only mild cerebellar retraction.
The IAC is initially opened with a cutting burr after dis-
placing of the dura, then a diamond burr is used to extent it
laterally to the limit of the tumor. In order to prevent hearing
loss, the limits of the vestibular duct are respected. When
the patient’s anatomy is not favorable for an extensive bone
removal without entering the bone labyrinth, a 70 degrees
oto-endoscope is used to visualize the fundus of the IAC.
During removal of posterior lip of the IAC, one should be
aware of a high jugular bulb that sometimes disturbs the
exposition. An arterial loop of the AICA can also be adherent
to the dura and must be dislocated with the dural flap in
order to have a complete tumor exposure.
Tumor removal may be initiated at either the CPA or at the
ICA, depending on the tumor size and its extension into the
IAC. It is important to postpone to the end of the surgery
the removal of the portion near the porus acusticus, where there
is greater adherence between the tumor and the cranial nerves.
After opening of the dura and complete the tumor
exposition in the IAC, a gentle debulking with an ultrasonic
surgical aspirator allows better handling of the VS in the nar-
row space. With a dissector, tumor is separated from the
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arachnoid that involves the nerves, and pulled in lateral to
medial direction towards the porus acusticus.
Once the IAC portion of the VS is removed, the dissec-
tion takes part in the CPA. This is an important surgical step
of the extracisternal approach and depends on the iden-
tification of the correct arachnoid plane of dissection.
Exposure of the posterior capsule is achieved retracting
the arachnoid that continues with the cerebellar par-
enchyma. It must be noted that the capsule, at this moment,
is still covered with a glittering membrane that represents
the arachnoid that follows the tumor in the CPA. If we
remove the tumor lateral to this membrane, we will come
across the neural structures in the CPA cistern, with no
arachnoid protection.
We proceed with tumor debulking to ease the dissection in
its whole circumference from the arachnoid membrane. The
goal is to obtain a thin capsule that can be bended and sepa-
rated from the correct arachnoid plane. Electrophysiological
monitoring and surgical ultrasound aspirator are used to avoid
traction of the nerves during tumor manipulation.
In our experience, it is easier to find the dissection plane
between tumor and arachnoid at the posterior region near
the porus, in the superior or inferior portions, where the
arachnoid is thicker or the vestibular nerves may be used
as a guide. Part of this membrane is formed by the vestibular
nerves that can be identified in smaller tumors. Vessels are
normally displaced anteriorly with the arachnoid membrane,
in a way that the tumor capsule remains opaque and devas-
cularized (Figure 1). Once the correct plane is achieved, a
blunt dissection with a micro-suction tube with low power
aspiration is performed until there is only a small residual
tumor anterior to the porus. In large VS, the same strategy
is used and progressed in a stepwise manner around the
tumor, focusing on keeping the plane of dissection.
Specifically in large tumors, the membrane can be disrupted
during removal due to tight adhesions in some parts of the
capsule. Changing the direction of dissection and continuing
with the same technique prevents from losing the correct
plane. A sharp dissection is recommended near the porus
acusticus, due to an arachnoid duplication and greater
adherence of the tumor.
In the classical technique, the dissection is done in an
inferior to superior direction to not cross with the facial
nerve. In our technique, the dissection is easier performed
and focused where the membrane is looser. The tumor rela-
tionship with the facial nerve is not our main concern and is
not the focus of the procedure. In most cases the nerve is
displaced anteriorly with the arachnoid membrane and pro-
tected by it (Figure 2).
Figure 1. (A) The dissection begins near the porus, where the
arachnoid is thicker and the dissection plane between tumor
(T) and the arachnoid membrane is easier found; (B) The tumor
capsule remains opaque and devascularized due to the
displacement of the vessels with the arachnoid membrane.
Figure 2. (A) VS in the left CPA; (B) The tumor (T) is dissected from the arachnoid (A) and the facial (F) and cochleo-vestibular (CV)
nerves are barely seen through the membrane; (C) end result with the nerves protected by the arachnoid; and (D) Postoperative
MRI demonstrating no residual tumor. F: Facial nerve; Tr: Trigeminal nerve; A: Arachnoid, P: Petrosal vein; L: Lower cranial nerves.
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After total removal, an envelope of arachnoidal sheath
covering the nerves in the CPA cistern can be identified
(Figures 3 and 4). In order to check for any residual tumor
or any opening of mastoid air cells, the fundus of the IAC
is inspected with a 70-degree oto-endoscope and filled with
muscle and fibrin glue. After dural closure, a vascularized
flap from sternocleidomastoid muscle is used to close mas-
toid air cells that were opened during craniotomy in order to
prevent CSF fistula.
Patients characteristics
Of the 120 patients treated, 8 patients were excluded
based on criteria: four patients with neurofibromatosis
type II, one patient previously treated with radiosurgery,
and three patients previously operated by other surgeons
with facial nerve palsy.
The extracisternal microsurgical resection was the first
treatment of the remaining 112 patients. The age range
was 16-80 years at the time of surgery (average 46 years),
extrameatal tumor sizes ranged from 5 to 45 mm (average
22 mm), and follow-up durations ranged from 1.0 to 7.4 years
(average 4.2 years).
Tumor removal
The 112 patients treated with surgery as first therapy
were divided according to the extra-meatal tumor size:
Class 1 (0-10 mm) with 9 patients (8.04%), Class 2
(11-20 mm) with 52 patients (46.43%), Class 3 (21-30 mm)
with 33 patients (29.46%), Class 4 (31-40 mm) with 11
patients (9.82%) and Class 5 (.40 mm) with 7 patients
(6.25%).
The extent of tumor resection was classified as GTR,
NTR or STR. In Class 1, GTR was achieved in 100% of the
patients. In Class 2, 96% of GTR and 4% of NTR was
achieved. Class 3 consisted in 79% of GTR, 18% of NTR
and 3% of STR. Class 4 patients had a 55% of GTR, 36% of
NTR and 9% of STR. There were no GTR in Class 5 patients,
with 86% of NTR and 14% of STR. Overall GTR was achieved
in 91 (81%) patients, NTR obtained in 18 (16%) patients and
STR in 3 (3%) patients (Table 1).
Figure 3. (A) VS in the right CPA; (B) Exposure of the posterior portion of the tumor (T) after opening of the internal auditory canal
(CAI); (C) The arachnoid envelop that protects the cranial nerves during dissection seen after total tumor removal; and (D)
Postoperative MRI demonstrating no residual tumor.
Figure 4. Some examples of arachnoid dissection in vestibular schwannoma surgery. Arac: Arachnoid; Tu: Tumor; VII: Facial nerve;
V: Trigeminal nerve.
Table 1. Extent of tumor resection reported in percentages and number of patients of each tumor class.
Class 1 Class 2 Class 3 Class 4 Class 5 Overall
GTR 100% (9) 96% (50) 79% (26) 55% (6) - 81% (91)
NTR - 4% (2) 18% (6) 36% (4) 86% (6) 16% (18)
STR - - 3% (1) 9% (1) 14% (1) 3% (3)
GTR: gross total resection; NTR: near-total resection; STR: subtotal removal.
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Facial nerve function
At the immediate postoperative period, good outcomes
(HB I-II) of facial nerve function were present in all
Class 1 patients, 87% of Class 2, 64% of Class 3, 82% of
Class 4 and 29% of Class 5 patients. Regular outcomes
(HB III) were present in 10% of Class 2, 24% of Class 3, 9%
of Class 4 and 29% of Class 5. Poor outcomes (HB IV-V) were
present in 4% of Class 2, 12% of Class 3, 9% of Class 4 and
43% of Class 5 patients. There were 4 cases of postoperative
delayed facial paralysis (onset usually at 8 days after surgery)
that improved uneventfully. None of the patients presented
with HB VI facial nerve dysfunction
One year after the surgery, facial nerve function improved
in all groups and presented good outcomes in 100% of the
cases in Classes 1 and 2 VS, 88% in Class 3, 100% in Class 4
and 43% in Class 5. Regular outcomes were present in 9% of
Class 3 and 29% of Class 5. Poor outcomes were present in
3% of Class 3 and 29% of Class 5 patients. Overall, facial nerve
function HB grades I and II at one year was 93% (Table 2).
Complications
We observed a few complications with variable causes
ranging from incision infection to pulmonary embolism,
but no deaths (Table 3). The overall CSF fistula rate was
8,9%. Since 2008, a systematic closure is performed with a
sternocleidomastoid muscle flap. If we analyze the CSF fis-
tula after the implementation of this closure technique,
the rate drops to 2,7%.
DISCUSSION
The dramatic evolution of results in the VS surgery in the
past decades has been credited to early diagnosis, improve-
ment in neuro-anesthesiology, intraoperative cranial nerve
monitoring and development of microsurgical techniques12,13,14.
However, surgeons still pursue the ideal management of VS
due to the importance of facial nerve function in the patients’
quality of life15.
The knowledge of microsurgical anatomy played an
important role decreasing morbidity and mortality rates.
The classical surgical technique of tumor debulking and
individualization of the neural structures in its most lateral
and medial portions was based on the anatomical descrip-
tions of the nerves in the internal auditory canal and on
the brainstem surface. Many anatomical reports described
important intraoperative references in order to facilitate
the identification of the cranial nerves proximal and distal
to the tumor, allowing its removal under direct vision of
neural structures12,13,14. Despite good anatomical knowledge,
finding the proximal facial nerve may be difficult, particu-
larly in large tumors.
The technical nuance described in this article permits
removal of the tumor without a direct visualization of the
facial nerve, as long as the arachnoid plane in the whole cir-
cumference of the tumor is respected. The avascular dissec-
tion plane was identified in all cases. Even in large VS, the
strategy of dissection was the same but performed in a step-
wise manner around the tumor. The importance of the pre-
servation of arachnoid around the nerves in acoustic
neuroma surgery has been established since Olivecrona in
194916. However, the cisternal arachnoid membranes ana-
tomy and its relationship with cranial nerves are controver-
sial, especially because of the difficulty preserving the
membranes on cadaveric specimens. The epiarachnoid or
subarachnoid origin of VS has been subject of discussion
and the presence of an arachnoid surgical plane between
tumor and cranial nerves questioned by some
authors17,18,19,20,21,22,23,24,25. This is not what we have experi-
enced during the surgical procedures, where the arachnoid
membrane is used as a protection to preserve the facial
nerve anatomically and functionally. We believe in a more
complex arachnoid anatomy at CPA with multiple layers
and different extension into the IAC, which needs to be fur-
ther studied.
It is known that the results on VS surgery depend more
on the individual surgeon’s experience than on the advan-
tages or disadvantages of a particular approach26. However,
it is our hypothesis that the application of the extracisternal
technique may reduce the surgeons’ learning curve and
improve VS surgical results. The results achieved by our
team with overall GTR in 81% and good facial nerve function
in 93% of the patients are among the best reported in the
recent literature6,26,27,28,29,30. We believe that the technical
Table 2. Facial nerve outcomes at one year, based on the House-Brackmann classification.
Class 1 Class 2 Class 3 Class 4 Class 5 Overall
Good (I-II) 100% (9) 100% (52) 88% (29) 100% (11) 43% (3) 93% (104)
Regular (III) - - 9% (3) - 29% (2) 4% (5)
Poor (IV-V-VI) - - 3% (1) - 29% (2) 3% (3)
Table 3. Complications.
Complications (number)
Class 1 none
Class 2 bulbar nerve paresis (1) - pulmonary embolism (1) -
incision infection (1) - cerebellar edema (1)
Class 3 pulmonary embolism (1) - incision infection (1) -
cerebellar edema (1) - hematoma (1)
Class 4 fibular nerve dysfunction (1)
Class 5 cerebellar venous infarct (1)
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nuance described has a major role on the outcome due to
the minimal facial nerve manipulation and mobilization.
In conclusion, the extracisternal technique differs from
others, as we do not have to expose the facial nerve at the
medial part of the tumor, as long as we can preserve a whole
envelop of arachnoid in the total circumference of the
tumor. The best results we experienced are the cases that
we cannot directly see the facial nerve after tumor removal.
Better anatomical studies are required to understand the
complex anatomy of the arachnoid membranes at CPA,
however, this technical nuance has improved our surgical
results.
References
1. Martin HC, Sethi J, Lang D, Neil-Dwyer G, LutmanME, Yardley L. Patient-
assessed outcomes after excision of acoustic neuroma: postoperative
symptoms and quality of life. J Neurosurg. 2001;94(2):211-6.
http://dx.doi.org/10.3171/jns.2001.94.2.0211
2. Gerganov VM, Klinge PM, Nouri M, Stieglitz L, Samii M, Samii A.
Prognostic clinical and radiological parameters for immediate facial
nerve function following vestibular schwannoma surgery. Acta
Neurochir (Wien). 2009;151(6):581-7. http://dx.doi.org/10.1007/s00701-
009-0288-3
3. Marouf R, Noudel R, Roche PH. Facial nerve outcome after
microsurgical resection of vestibular schwannoma. Prog Neurol
Surg. 2008;21:103-7. 10.1159/000156714
4. Yang I, Sughrue ME, Han SJ, Fang S, Aranda D, Cheung SW et al. Facial
nerve preservation after vestibular schwannoma Gamma Knife radio-
surgery. J Neurooncol. 2009;93:41-8. 10.1007/s11060-009-9842-3
5. Carlson ML, Van Abel KM, Schmitt WR, Driscoll CL, Neff BA, Link MJ.
The anatomically intact but electrically unresponsive facial nerve in
vestibular schwannoma surgery. Neurosurgery. 2012;71(6):1125-30.
http://dx.doi.org/10.1227/NEU.0b013e318271bce3
6. Samii M, Matthies C. Management of 1000 vestibular schwannomas
(acoustic neuromas): the facial nerve: preservation and restitution of
function. Neurosurgery. 1997;40(4):684-95. http://dx.doi.org/10.1097/
00006123-199704000-00006
7. Tamura M, Murata N, Hayashi M, Roche PH, Régis J. Facial nerve
function insufficiency after radiosurgery versus microsurgery. Prog
Neurol Surg. 2008;21:108-18. http://dx.doi.org/10.1159/000156718
8. Youssef AS, Downes AE. Intraoperative neurophysiological monitoring
in vestibular schwannoma surgery: advances and clinical implications.
Neurosurg Focus. 2009;27(4):E9. http://dx.doi.org/10.3171/2009.8.
focus09144
9. Kanzaki J, Tos M, Sanna M, Moffat DA, Monsell EM, Berliner KI. New
and modified reporting systems from the consensus meeting on
systems for reporting results in vestibular schwannoma. Otol
Neurotol. 2003;24(4):642-8. http://dx.doi.org/10.1097/00129492-
200307000-00019
10. Bloch DC, Oghalai JS, Jackler RK, Osofsky M, Pitts LH. The fate of the
tumor remnant after less-than-complete acoustic neuroma resec-
tion. Otolaryngol Head Neck Surg. 2004;130(1):104-12. http://dx.doi.
org/10.1016/s0194-5998(03)01598-5
11. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol
Head Neck Surg. 1985;93(2):146-7.
12. Ciric I, Zhao JC, Rosenblatt S, Wiet R, O’Shaughnessy B.
Suboccipital retrosigmoid approach for removal of vestibular
schwannomas: facial nerve function and hearing preservation.
Neurosurgery. 2005;56(3):560-70. http://dx.doi.org/10.1227/01.neu.
0000154059.34990.b8
13. Gharabaghi A, Samii A, Koerbel A, Rosahl SK, Tatagiba M, Samii M.
Preservation of function in vestibular schwannoma surgery.
Neurosurgery. 2007;60(2 Suppl 1):124-7. http://dx.doi.org/10.1227/
01.neu.0000249245.10182.0d
14. Malis LI. Nuances in acoustic neuroma surgery. Neurosurgery.
2001;49(2):337-41. http://dx.doi.org/10.1227/00006123-200108000-
00015
15. Haque R, Wojtasiewicz TJ, Gigante PR, Attiah MA, Huang B, Isaacson
SR et al. Efficacy of facial nerve-sparing approach in patients
with vestibular schwannomas. J Neurosurg. 2011;115(5):917-23.
http://dx.doi.org/10.3171/2011.7.jns101921
16. Olivercrona H. Acoustic tumours. J Neurol Psychiat. 1940;3(2):141-6.
10.1136/jnnp.3.2.141
17. Kohno M, Sato H, Sora S, Miwa H, Yokoyama M. Is an acoustic
neuroma an epiarachnoid or subarachnoid tumor? Neurosurgery.
2011;68(4):1006-16. http://dx.doi.org/10.1227/NEU.0b013e318208f37f
18. Kuo TC, Jackler RK, Wong K, Blevins NH, Pitts LH. Are acoustic
neuromas encapsulated tumors? Otolaryngol Head Neck Sur.
1997;117(6):606-9. http://dx.doi.org/10.1016/s0194-5998(97)70040-8
19. Lescanne E, Francxois P, Bakhos D, Velut S, Robier A, Pollak A.
Vestibular schwannoma dissection of the tumor and arachnoid
duplication. Otol Neurotol. 2008;29(7):989-94. http://dx.doi.org/10.1097/
MAO.0b013e3181845812
20. Lescanne E, Velut S, Lefrancq T, Destrieux C. The internal acoustic
meatus and its meningeal layers: a microanatomical study. J
Neurosurg. 2002;97(5):1191-7. 10.3171/jns.2002.97.5.1191
21. Luetje CM, Whittaker CK, Callaway LA, Veraga G. Histological
acoustic tumor involvement of the VIIth nerve and multicentric origin
in the VIIIth nerve. Laryngoscope. 1983;93(9):1133-9. http://dx.doi.
org/10.1288/00005537-198309000-00004
22. Neely JG. Gross and microscopic anatomy of the eighth cranial
nerve in relationship to the solitary schwannoma. Laryngoscope.
1981;91(9):1512-31. http://dx.doi.org/10.1288/00005537-198109000-
00015
23. Ohata K, Tsuyuguchi N, Morino M, Takami T, Goto T, Hakuba A et al. A
hypothesis of epiarachnoidal growth of vestibular schwannoma at
the cerebello-pontine angle: surgical importance. J Postgrad Med.
2002;48(4):253-8.
24. Rhoton A L Jr. The posterior fossa cisterns. Neurosurgery
2000;47(Suppl):S287-97.
25. Yasargil MG, Smith RD, Gasser JC. Microsurgical approach to
acoustic neurinoma. In Krayenbuhl H, editor. Advances and technical
standards in neurosurgery. Wien: Springer; 1977. p. 94-129.
26. Samii M, Gerganov V, Samii A. Improved preservation of hearing and
facial nerve function in vestibular schwannoma surgery via the
retrosigmoid approach in a series of 200 patients. J Neurosurg.
2006;105(4):527-35. http://dx.doi.org/10.3171/jns.2006.105.4.527
27. Brackmann DE, Cullen RD, Fisher LM. Facial nerve function after
translabyrinthine vestibular schwannoma surgery. Otolaryngol Head
Neck Surg. 2007;136(5):773-7. 10.1016/j.otohns.2006.10.009
28. Briggs RJ, LuxfordWM, Atkins JS Jr, HitselbergerWE. Translabyrinthine
removal of large acoustic neuromas. Neurosurgery. 1994;34(5):785-90.
http://dx.doi.org/10.1227/00006123-199405000-00001
29. Bruzzo M, Broder L, Chays A, Magnan J. Our current results with
acoustic neurinoma surgery. Ann Otolaryngol Chir Cervicofac.
2000;117(2):110-7.
30. Colletti V, Fiorino FG. Retrosigmoid-transmeatal en bloc removal of small
to medium-sized acoustic neuromas. Otolaryngol Head Neck Surg.
1999;120(1):122-8. http://dx.doi.org/10.1016/s0194-5998(99)70382-7
930 Arq Neuropsiquiatr 2014;72(12):925-930
